drugset
drugset / Trial / NCT04862884

A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

NCT04862884 ↗

Phase 1 Unknown 50 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The study will be conducted to evaluate the safety and PK profile of HRS4800 tablets after single oral administration in different dose levels compared to placebo.

Timeline

Start
2021-05-03
Primary completion
2021-09-03
Completion
2021-09-24

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS4800 Unknown — Oral

Indications

No indication recorded.